EPISODE · Dec 30, 2022 · 45 MIN
Omidenepag: A New Category of Topical Glaucoma Therapy
from Experts InSight
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
NOW PLAYING
Omidenepag: A New Category of Topical Glaucoma Therapy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m